IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Enliven Therapeutics Inc

CUSIP: 29337E103 | 1 institutional holders

Quarters

Q1 2026
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2026

Seven Fleet Capital Management LP95,253
1.2% of portfolio›$3.7M
StyleTurnoverLocationFiled
Seven Fleet Capital Management LP
95,253$3.7M1.2%GrowthVery HighMountain View, CA2026-06-04